Latest Articles
Breakthrough: Acrivon's Cancer Drug Shows 35% Response Rate in Resistant Endometrial Cancer Patients - Stock Titan
Breakthrough: Acrivon's Cancer Drug Shows 35% Response Rate in Resistant Endometrial Cancer Patients Stock Titan
Published: May 14, 2025, 8:10 p.m.
VIDEO: Puxitatug samrotecan shows promise for patients with recurrent endometrial cancer - Healio
VIDEO: Puxitatug samrotecan shows promise for patients with recurrent endometrial cancer Healio
Published: May 14, 2025, 8:04 p.m.
Comprehensive analyses of telomerase component DKC1 and its association with clinical, molecular and immune landscapes in uterine corpus endometrial carcinoma - Frontiers
Comprehensive analyses of telomerase component DKC1 and its association with clinical, molecular and immune landscapes in uterine corpus endometrial carcinoma Frontiers
Published: May 12, 2025, 7:50 p.m.
Early-Onset Breast, Colorectal, Endometrial, Pancreatic, and Kidney Cancers on the Rise - The ASCO Post
Early-Onset Breast, Colorectal, Endometrial, Pancreatic, and Kidney Cancers on the Rise The ASCO Post
Published: May 12, 2025, 2:24 p.m.
Guidance for Community Oncologists: Expert Advice on Treating Patients With Endometrial Cancer - OncLive
Guidance for Community Oncologists: Expert Advice on Treating Patients With Endometrial Cancer OncLive
Published: May 12, 2025, 12:39 p.m.
Robotic Surgery Systems for Endometrial Cancer Market Emerging Trends and Growth Prospects 2034 - openPR.com
Robotic Surgery Systems for Endometrial Cancer Market Emerging Trends and Growth Prospects 2034 openPR.com
Published: May 12, 2025, 10:53 a.m.
DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer - Nature
DNA glycosylase (NEIL3) overexpression associated with low tumor immune infiltration and poor overall patient survival in endometrial cancer Nature
Published: May 10, 2025, 10:19 a.m.
Dr Wagar on the Use of T-DXd in Patients With HER2+ Endometrial Cancer - OncLive
Dr Wagar on the Use of T-DXd in Patients With HER2+ Endometrial Cancer OncLive
Published: May 9, 2025, 11:26 p.m.
Expanding Endometrial Ablation Devices Market In Response To The Rising Prevalence Of Gynecological Disorde... - WhaTech
Expanding Endometrial Ablation Devices Market In Response To The Rising Prevalence Of Gynecological Disorde... WhaTech
Published: May 9, 2025, 2:27 p.m.
Endometrial Resection Device Market Industry Analysis by Size, - openPR.com
Endometrial Resection Device Market Industry Analysis by Size, openPR.com
Published: May 9, 2025, 1:07 p.m.
Link copied to clipboard!